首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of pharmacology and experimental therapeutics

缩写:J PHARMACOL EXP THER

ISSN:0022-3565

e-ISSN:1521-0103

IF/分区:4.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5146条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Dengpiao Xie,Juan Wang,Gaizun Hu et al. Dengpiao Xie et al.
Inhibition of hypoxia-inducible factor-prolyl hydroxylase (PHD) has been shown to protect against various kidney diseases. However, there are controversial reports on the effect of PHD inhibition in renoprotection. The present study determi...
Keivan Golshiri,Ehsan Ataei Ataabadi,Eloísa Rubio-Beltran et al. Keivan Golshiri et al.
Diminished nitric oxide-cGMP-mediated relaxation plays a crucial role in cardiovascular aging, leading to decreased vasodilation, vascular hypertrophy and stiffening, and ultimately, cardiovascular dysfunction. Aging is the time-related wor...
V Sashi Gopaul,Anna Vildhede,Tommy B Andersson et al. V Sashi Gopaul et al.
Verinurad is a selective uric acid transporter 1 (URAT1) inhibitor in development for the treatment of chronic kidney disease and heart failure. In humans, two major acyl glucuronide metabolites have been identified: direct glucuronide M1 a...
Nathaniel G Girer,Victoria G Rontoyanni,Aditya Joshi et al. Nathaniel G Girer et al.
Viral-mediated in vivo gene delivery methods currently dominate among therapeutic strategies within the clinical and experimental settings, albeit with well documented limitations arising from immunologic constraints. In this study, we demo...
Rucha S Sane,Kit Wun Kathy Cheung,Eunpi Cho et al. Rucha S Sane et al.
Ipatasertib is a pan-AKT inhibitor in development for the treatment of cancer. Ipatasertib was metabolized by CYP3A4 to its major metabolite, M1 (G-037720), and was a P-gp substrate and OATP1B1/1B3 inhibitor in vitro. A phase I drug-drug in...
Kaye E Dandrea,Joseph F Cotten Kaye E Dandrea
Potent synthetic opioids are an important cause of death in the United States' opioid epidemic, and a breathing stimulant may have utility in treating opioid overdose. We hypothesized that sufentanil-induced respiratory depression may be re...
L Hinder,A L Pfaff,R E Emmerich et al. L Hinder et al.
Ferroptosis is a form of oxidative cell death that is increasingly recognized as a key mechanism not only in neurodegeneration but also in regulated cell death, causing disease in other tissues. In neurons, major hallmarks of ferroptosis in...
Beth Youngblood,Kevin Li,Donald R Gehlert et al. Beth Youngblood et al.
Opioid use disorder (OUD) is a major socioeconomic burden. An ideal OUD pharmacotherapy will mitigate the suffering associated with opioid-withdrawal, inhibit the effects of high efficacy opioids, and minimize opioid-cravings while being sa...